# PRKCB

## Overview
The PRKCB gene encodes the protein kinase C beta (PKCβ), a member of the serine/threonine kinase family, which plays a crucial role in various cellular signaling pathways. PKCβ is involved in regulating processes such as cell proliferation, differentiation, apoptosis, and immune responses, particularly in B cells where it influences germinal center formation and plasma cell differentiation (Tsui2018Protein). The protein's activity is modulated by calcium and phospholipid interactions, which facilitate its localization to specific membrane compartments, thereby influencing its function in signal transduction (MELLOR1998The). PRKCB is also implicated in vascular responses and chromatin remodeling, with its dysregulation linked to various diseases, including autism, diabetic nephropathy, and certain cancers (AlTu’ma2022A; Surdez2012Targeting; Philippi2005Haplotypes). The gene's alternative splicing results in different isoforms, β1 and β2, which have distinct roles in cellular signaling (Greenham1998Elucidation).

## Structure
The PRKCB gene encodes protein kinase C beta, a serine/threonine kinase involved in various cellular processes. The primary structure of PRKCB includes specific amino acid sequences that form functional domains such as the C1 domain, which binds diacylglycerol, and the C2 domain, which binds calcium (EudeLe2007Protein). These domains are crucial for the activation and function of the protein. The secondary structure of PRKCB features alpha helices and beta sheets, which contribute to the protein's stability and function. The tertiary structure involves the folding of these domains into a three-dimensional conformation necessary for its enzymatic activity. 

PRKCB undergoes post-translational modifications, including phosphorylation, which is essential for its maturation and stability (Van2021Protein). The gene is alternatively spliced to produce different isoforms, specifically the β1 and β2 isoenzymes, which differ in their carboxy-terminal amino acids (Greenham1998Elucidation). These isoforms are part of the classical PKC family and have distinct roles in cellular signaling pathways. The quaternary structure may involve interactions with other proteins, although specific details are not provided in the context. The structural features of PRKCB are integral to its function in signal transduction and other cellular processes.

## Function
Protein kinase C beta (PKCβ), encoded by the PRKCB gene, is a serine/threonine kinase that plays a pivotal role in various cellular processes. It is involved in signal transduction pathways that regulate cell proliferation, differentiation, and apoptosis. PKCβ is highly expressed in B cells, where it is crucial for immune responses, including the formation of germinal centers and plasma cell differentiation. It facilitates metabolic reprogramming and mitochondrial remodeling, which are essential for B cell activation and fate determination (Tsui2018Protein).

PKCβ is also involved in the regulation of mTORC1 signaling, which is critical for early B cell activation and plasma cell differentiation. This signaling pathway is characterized by ribosomal protein S6 phosphorylation and the expression of surface markers such as CD98 and CD71. In the absence of PKCβ, there is a reduction in mTORC1 activity, leading to impaired plasma cell differentiation and increased mitochondrial reactive oxygen species accumulation (Tsui2018Protein).

In addition to its role in immune cells, PKCβ is implicated in vascular responses. It is associated with the smooth muscle contraction cascade, influencing vasoconstriction through interactions with α2-adrenoceptors and other signaling pathways (Posti2013A). PKCβ's activity is regulated by calcium and phospholipid interactions, which target the kinase to specific membrane compartments, facilitating its role in cellular signaling (MELLOR1998The).

## Clinical Significance
Mutations and alterations in the PRKCB gene have been implicated in several diseases. In autism, significant genetic linkages have been identified on chromosome 16, particularly involving the PRKCB1 gene. Specific single-nucleotide polymorphisms (SNPs) within this gene, such as the T-allele of SNP 128, have shown strong associations with autism, suggesting that changes in PRKCB1 expression or mutations could contribute to the condition (Philippi2005Haplotypes).

In diabetic nephropathy, the PRKCB gene polymorphism rs3760106 is associated with increased susceptibility in patients with type 2 diabetes mellitus. This polymorphism correlates with elevated protein kinase C (PKC) activity levels, which are linked to renal complications (AlTu’ma2022A).

The PRKCB gene is also associated with low-frequency hearing loss in familial Meniere's disease. A novel missense variant in PRKCB has been identified, suggesting that haploinsufficiency may lead to hearing loss by affecting cochlear function (MartínSierra2016A).

Additionally, PRKCB has been identified as a genetic susceptibility locus for primary biliary cholangitis in the Japanese population, with specific SNPs affecting gene expression levels and contributing to disease susceptibility (Kawashima2017Genomewide).

## Interactions
PRKCB (protein kinase C beta) is involved in various protein interactions that influence cellular processes. It interacts with Signal Transducers and Activators of Transcription 3 (Stat3), a transcription factor involved in multiple cellular functions. The interaction between PRKCB and Stat3 was confirmed using methods such as Surface Plasmon Resonance (SPR) and co-immunoprecipitation, revealing a moderate affinity with a dissociation constant (K D) of 610 nM (Zheng2012QUICK). This interaction suggests a role for PRKCB in regulating Stat3 activity, which is significant in the context of multiple myeloma (Zheng2012QUICK).

In Alzheimer's disease, PRKCB shows altered expression and interaction patterns, acting as a gene hub with several correlations to other genes, including MAP1S, COX6B1, and POLG. These interactions are visualized in gene networks, indicating PRKCB's central role in gene connectivity and potential involvement in disease mechanisms (Antonell2015Altered).

In Ewing sarcoma, PRKCB is an active kinase that phosphorylates histone H3, affecting histone methylation and cell survival. Its inhibition leads to decreased cell proliferation and increased apoptosis, highlighting its role in chromatin remodeling and tumor growth (Surdez2012Targeting).


## References


[1. (Greenham1998Elucidation) Jaimie Greenham, Mark Adams, Norman Doggett, and S. Mole. Elucidation of the exon-intron structure and size of the human protein kinase c beta gene ( prkcb ). Human Genetics, 103(4):483–487, November 1998. URL: http://dx.doi.org/10.1007/s004390050854, doi:10.1007/s004390050854. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390050854)

[2. (Zheng2012QUICK) Peng Zheng, Qiu Zhong, Qian Xiong, Mingkun Yang, Jia Zhang, Chongyang Li, Li-Jun Bi, and Feng Ge. Quick identification and spr validation of signal transducers and activators of transcription 3 (stat3) interacting proteins. Journal of Proteomics, 75(3):1055–1066, January 2012. URL: http://dx.doi.org/10.1016/j.jprot.2011.10.020, doi:10.1016/j.jprot.2011.10.020. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.jprot.2011.10.020)

[3. (Van2021Protein) An-Angela N. Van, Maya T. Kunkel, Timothy R. Baffi, Gema Lordén, Corina E. Antal, Sourav Banerjee, and Alexandra C. Newton. Protein kinase c fusion proteins are paradoxically loss of function in cancer. Journal of Biological Chemistry, 296:100445, January 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100445, doi:10.1016/j.jbc.2021.100445. This article has 28 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100445)

[4. (MartínSierra2016A) Carmen Martín-Sierra, Teresa Requena, Lidia Frejo, Steven D. Price, Alvaro Gallego-Martinez, Angel Batuecas-Caletrio, Sofía Santos-Pérez, Andrés Soto-Varela, Anna Lysakowski, and Jose A. Lopez-Escamez. A novel missense variant inprkcbsegregates low-frequency hearing loss in an autosomal dominant family with meniere’s disease. Human Molecular Genetics, 25(16):3407–3415, June 2016. URL: http://dx.doi.org/10.1093/hmg/ddw183, doi:10.1093/hmg/ddw183. This article has 53 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddw183)

[5. (Kawashima2017Genomewide) Minae Kawashima, Yuki Hitomi, Yoshihiro Aiba, Nao Nishida, Kaname Kojima, Yosuke Kawai, Hitomi Nakamura, Atsushi Tanaka, Mikio Zeniya, Etsuko Hashimoto, Hiromasa Ohira, Kazuhide Yamamoto, Masanori Abe, Kazuhiko Nakao, Satoshi Yamagiwa, Shuichi Kaneko, Masao Honda, Takeji Umemura, Takafumi Ichida, Masataka Seike, Shotaro Sakisaka, Masaru Harada, Osamu Yokosuka, Yoshiyuki Ueno, Michio Senju, Tatsuo Kanda, Hidetaka Shibata, Takashi Himoto, Kazumoto Murata, Yasuhiro Miyake, Hirotoshi Ebinuma, Makiko Taniai, Satoru Joshita, Toshiki Nikami, Hajime Ota, Hiroshi Kouno, Hirotaka Kouno, Makoto Nakamuta, Nobuyoshi Fukushima, Motoyuki Kohjima, Tatsuji Komatsu, Toshiki Komeda, Yukio Ohara, Toyokichi Muro, Tsutomu Yamashita, Kaname Yoshizawa, Yoko Nakamura, Masaaki Shimada, Noboru Hirashima, Kazuhiro Sugi, Keisuke Ario, Eiichi Takesaki, Atsushi Naganuma, Hiroshi Mano, Haruhiro Yamashita, Kouki Matsushita, Kazuhiko Yamauchi, Fujio Makita, Hideo Nishimura, Kiyoshi Furuta, Naohiro Takahashi, Masahiro Kikuchi, Naohiko Masaki, Tomohiro Tanaka, Sumito Tamura, Akira Mori, Shintaro Yagi, Ken Shirabe, Atsumasa Komori, Kiyoshi Migita, Masahiro Ito, Shinya Nagaoka, Seigo Abiru, Hiroshi Yatsuhashi, Michio Yasunami, Shinji Shimoda, Kenichi Harada, Hiroto Egawa, Yoshihiko Maehara, Shinji Uemoto, Norihiro Kokudo, Hajime Takikawa, Hiromi Ishibashi, Kazuaki Chayama, Masashi Mizokami, Masao Nagasaki, Katsushi Tokunaga, and Minoru Nakamura. Genome-wide association studies identifyprkcbas a novel genetic susceptibility locus for primary biliary cholangitis in the japanese population. Human Molecular Genetics, pages ddw406, January 2017. URL: http://dx.doi.org/10.1093/hmg/ddw406, doi:10.1093/hmg/ddw406. This article has 11 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddw406)

[6. (EudeLe2007Protein) Isabelle Eude-Le Parco, Emmanuelle Dallot, and Michelle Breuiller-Fouché. Protein kinase c and human uterine contractility. BMC Pregnancy and Childbirth, June 2007. URL: http://dx.doi.org/10.1186/1471-2393-7-S1-S11, doi:10.1186/1471-2393-7-s1-s11. This article has 19 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/1471-2393-7-S1-S11)

[7. (AlTu’ma2022A) Fadhil Jawad Al-Tu’ma and Zahraa Abdul Adheem Al-Maiyaly. A novel study of protein kinase c beta gene polymorphism (rs3760106) and protein kinase c activity levels as a predictor of nephropathy complications in iraqi diabetic patients. Journal of Contemporary Medical Sciences, April 2022. URL: http://dx.doi.org/10.22317/jcms.v8i2.1204, doi:10.22317/jcms.v8i2.1204. This article has 0 citations.](https://doi.org/10.22317/jcms.v8i2.1204)

[8. (Surdez2012Targeting) Didier Surdez, Magdalena Benetkiewicz, Virginie Perrin, Zhi-Yan Han, Gaëlle Pierron, Stelly Ballet, François Lamoureux, Françoise Rédini, Anne-Valérie Decouvelaere, Estelle Daudigeos-Dubus, Birgit Geoerger, Gonzague de Pinieux, Olivier Delattre, and Franck Tirode. Targeting the ewsr1-fli1 oncogene-induced protein kinase pkc-β abolishes ewing sarcoma growth. Cancer Research, 72(17):4494–4503, August 2012. URL: http://dx.doi.org/10.1158/0008-5472.can-12-0371, doi:10.1158/0008-5472.can-12-0371. This article has 76 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-12-0371)

[9. (Tsui2018Protein) Carlson Tsui, Nuria Martinez-Martin, Mauro Gaya, Paula Maldonado, Miriam Llorian, Nathalie M. Legrave, Merja Rossi, James I. MacRae, Angus J. Cameron, Peter J. Parker, Michael Leitges, Andreas Bruckbauer, and Facundo D. Batista. Protein kinase c-β dictates b cell fate by regulating mitochondrial remodeling, metabolic reprogramming, and heme biosynthesis. Immunity, 48(6):1144-1159.e5, June 2018. URL: http://dx.doi.org/10.1016/j.immuni.2018.04.031, doi:10.1016/j.immuni.2018.04.031. This article has 82 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2018.04.031)

[10. (MELLOR1998The) Harry MELLOR and Peter J. PARKER. The extended protein kinase c superfamily. Biochemical Journal, 332(2):281–292, June 1998. URL: http://dx.doi.org/10.1042/bj3320281, doi:10.1042/bj3320281. This article has 1191 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1042/bj3320281)

[11. (Philippi2005Haplotypes) A Philippi, E Roschmann, F Tores, P Lindenbaum, A Benajou, L Germain-Leclerc, C Marcaillou, K Fontaine, M Vanpeene, S Roy, S Maillard, V Decaulne, J P Saraiva, P Brooks, F Rousseau, and J Hager. Haplotypes in the gene encoding protein kinase c-beta (prkcb1) on chromosome 16 are associated with autism. Molecular Psychiatry, 10(10):950–960, July 2005. URL: http://dx.doi.org/10.1038/sj.mp.4001704, doi:10.1038/sj.mp.4001704. This article has 56 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/sj.mp.4001704)

[12. (Antonell2015Altered) Anna Antonell, Albert Lladó, Raquel Sánchez-Valle, Coral Sanfeliu, Teresa Casserras, Lorena Rami, Cristina Muñoz-García, Adrià Dangla-Valls, Mircea Balasa, Patricia Boya, Susana G Kalko, and José Luis Molinuevo. Altered blood gene expression of tumor-related genes (prkcb, becn1, and cdkn2a) in alzheimer’s disease. Molecular Neurobiology, 53(9):5902–5911, October 2015. URL: http://dx.doi.org/10.1007/s12035-015-9483-9, doi:10.1007/s12035-015-9483-9. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s12035-015-9483-9)

[13. (Posti2013A) Jussi P. Posti, Perttu Salo, Saku Ruohonen, Laura Valve, Mordechai Muszkat, Gbenga G. Sofowora, Daniel Kurnik, Charles Michael Stein, Markus Perola, Mika Scheinin, and Amir Snapir. A polymorphism in the protein kinase c gene prkcb is associated with α2-adrenoceptor-mediated vasoconstriction. Pharmacogenetics and Genomics, 23(3):127–134, March 2013. URL: http://dx.doi.org/10.1097/fpc.0b013e32835d247f, doi:10.1097/fpc.0b013e32835d247f. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1097/fpc.0b013e32835d247f)